NASDAQ Companies

Project: AI based Assay Development for carbapenem-resistance based on porin loss and efflux pump overexpression in Gram-negative bacteriaProject is part […]

LEXINGTON, Mass. and AMSTERDAM, Sept. 30, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing […]

GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management […]

RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced new data from treatment-naïve […]

–Preparing to Submit NDA in Q4–DUBLIN, Ireland and CHICAGO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) […]

MOUNTAIN VIEW, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on […]

SHANGHAI, China, Sept. 30, 2020 (GLOBE NEWSWIRE) — Q&K International Group Limited (NASDAQ: QK) (“Q&K” or the “Company”), a leading […]

LONDON, Sept. 30, 2020 (GLOBE NEWSWIRE) — In a market update for clients, Willis Towers Watson (NASDAQ: WLTW), a leading […]

HANGZHOU, China, Sept. 30, 2020 (GLOBE NEWSWIRE) — Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social […]

SHANGHAI, China, Sept. 30, 2020 (GLOBE NEWSWIRE) — Huazhu Group Limited (Nasdaq: HTHT and HKEx: 1179), a leading and fast-growing […]